Solution structure of a biologically active human FGF-1 monomer, complexed to a hexasaccharide heparin-analogue
NLPPGNYKKP KLLYCSNGGH FLRILPDGTV DGTRDRSDQH IQLQLSAESV GEVYIKSTET GQYLAMDTDG LLYGSQTPNE ECLFLERLEE NHYNTYISKK HAEKNWFVGL KKNGSCKRGP RTHYGQKAIL FLPLPVSSD
ID | Type | Value order | Atom ID 1 | Atom ID 2 |
---|---|---|---|---|
1 | covalent | sing | 2:IDS1:O4 | 2:GNS2:C1 |
2 | covalent | sing | 2:GNS2:O4 | 2:IDR3:C1 |
3 | covalent | sing | 2:IDR3:O4 | 2:NGY4:C1 |
4 | covalent | sing | 2:NGY4:O4 | 2:IDS5:C1 |
5 | covalent | sing | 2:IDS5:O4 | 2:GNS6:C1 |
6 | covalent | sing | 2:GNS6:O4 | 2:IPA7:C2 |
Polymer type: polypeptide(L) polysaccharide(D)
Total | 1H | 13C | 15N | |
---|---|---|---|---|
All | 66.6 % (1091 of 1638) | 79.2 % (680 of 859) | 45.0 % (285 of 633) | 86.3 % (126 of 146) |
Backbone | 78.5 % (642 of 818) | 93.6 % (265 of 283) | 63.6 % (257 of 404) | 91.6 % (120 of 131) |
Sidechain | 49.7 % (470 of 946) | 72.0 % (415 of 576) | 13.8 % (49 of 355) | 40.0 % (6 of 15) |
Aromatic | 44.1 % (60 of 136) | 88.2 % (60 of 68) | 0.0 % (0 of 67) | 0.0 % (0 of 1) |
Methyl | 54.5 % (72 of 132) | 89.4 % (59 of 66) | 19.7 % (13 of 66) |
1. FGF-1
NLPPGNYKKP KLLYCSNGGH FLRILPDGTV DGTRDRSDQH IQLQLSAESV GEVYIKSTET GQYLAMDTDG LLYGSQTPNE ECLFLERLEE NHYNTYISKK HAEKNWFVGL KKNGSCKRGP RTHYGQKAIL FLPLPVSSDTemperature 298 (±0.2) K, pH 6.0 (±0.2), Details 90% H2O, 10% D2O
# | Name | Isotope labeling | Type | Concentration |
---|---|---|---|---|
1 | acidic fibroblast growth factor | [U-95% 15N] | 1 mM | |
2 | heparin like hexasaccharide | 1 mM | ||
3 | sodium phosphate | 10 mM | ||
4 | sodium chloride | 150 mM | ||
5 | 3-trimethylsilylpropionate | 1 mM |
Temperature 298 (±0.2) K, pH 6.0 (±0.2)
# | Name | Isotope labeling | Type | Concentration |
---|---|---|---|---|
6 | acidic fibroblast growth factor | [U-95% 13C; U-95% 15N] | 1 mM | |
7 | heparin like hexasaccharide | 1 mM | ||
8 | sodium phosphate | 10 mM | ||
9 | sodium chloride | 150 mM | ||
10 | 3-trimethylsilylpropionate | 1 mM |